Evidence map›Paper›PMID 34181702›Full record

ArticlePLoS pathogens2021

Asymmetric-flow field-flow fractionation of prions reveals a strain-specific continuum of quaternary structures with protease resistance developing at a hydrodynamic radius of 15 nm.

Leonardo M Cortez, Satish K Nemani, Camilo Duque Velásquez, Aishwarya Sriraman, YongLiang Wang, Holger Wille, Debbie McKenzie, Valerie L Sim

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. BSE risk posed by ruminant collagen and gelatine derived from bones.EFSA journal. European Food Safety Authority · 2024
    Article
  6. Review
  7. Propagation of PrPCommunications biology · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.Protein science : a publication of the Protein Society · 2022
    Article
  12. Article
  13. Structural biology of ex vivo mammalian prions.The Journal of biological chemistry · 2022
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Leonardo M CortezCentre for Prions and Protein Folding Diseases, Edmonton, Alberta, Canada.ORCID 0000-0003-4080-8728
Satish K NemaniCentre for Prions and Protein Folding Diseases, Edmonton, Alberta, Canada.ORCID 0000-0003-0505-3577
Camilo Duque VelásquezCentre for Prions and Protein Folding Diseases, Edmonton, Alberta, Canada.
Aishwarya SriramanCentre for Prions and Protein Folding Diseases, Edmonton, Alberta, Canada.ORCID 0000-0001-6618-4672
YongLiang WangCentre for Prions and Protein Folding Diseases, Edmonton, Alberta, Canada.
Holger WilleCentre for Prions and Protein Folding Diseases, Edmonton, Alberta, Canada.ORCID 0000-0001-5102-8706
Debbie McKenzieCentre for Prions and Protein Folding Diseases, Edmonton, Alberta, Canada.ORCID 0000-0002-9291-6977
Valerie L SimCentre for Prions and Protein Folding Diseases, Edmonton, Alberta, Canada.ORCID 0000-0002-0088-8666
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prion diseases are transmissible neurodegenerative disorders that affect mammals, including humans. The central molecular event is the conversion of cellular prion glycoprotein, PrPC, into a plethora of assemblies, PrPSc, associated with disease. Distinct phenotypes of disease led to the concept of prion strains, which are associated with distinct PrPSc structures. However, the degree to which intra- and inter-strain PrPSc heterogeneity contributes to disease pathogenesis remains unclear. Addressing this question requires the precise isolation and characterization of all PrPSc subpopulations from the prion-infected brains. Until now, this has been challenging. We used asymmetric-flow field-flow fractionation (AF4) to isolate all PrPSc subpopulations from brains of hamsters infected with three prion strains: Hyper (HY) and 263K, which produce almost identical phenotypes, and Drowsy (DY), a strain with a distinct presentation. In-line dynamic and multi-angle light scattering (DLS/MALS) data provided accurate measurements of particle sizes and estimation of the shape and number of PrPSc particles. We found that each strain had a continuum of PrPSc assemblies, with strong correlation between PrPSc quaternary structure and phenotype. HY and 263K were enriched with large, protease-resistant PrPSc aggregates, whereas DY consisted primarily of smaller, more protease-sensitive aggregates. For all strains, a transition from protease-sensitive to protease-resistant PrPSc took place at a hydrodynamic radius (Rh) of 15 nm and was accompanied by a change in glycosylation and seeding activity. Our results show that the combination of AF4 with in-line MALS/DLS is a powerful tool for analyzing PrPSc subpopulations and demonstrate that while PrPSc quaternary structure is a major contributor to PrPSc structural heterogeneity, a fundamental change, likely in secondary/tertiary structure, prevents PrPSc particles from maintaining proteinase K resistance below an Rh of 15 nm, regardless of strain. This results in two biochemically distinctive subpopulations, the proportion, seeding activity, and stability of which correlate with prion strain phenotype.

Indexed as

AnimalsCricetinaeDynamic Light ScatteringHydrodynamicsMicePhotometryProtein Structure, QuaternaryPrPSc ProteinsPrPSc Proteins

Identifiers

PMID34181702
PMCPMC8270404
OpenAlexW3176167285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.